(Q34652628)
Statements
1 reference
Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study (English)
1 reference
Dirk Schadendorf
1 reference
Reinhard Dummer
1 reference
Ralf Gutzmer
1 reference
Kevin B Kim
1 reference
Marta Nyakas
1 reference
Gabriella Liszkay
1 reference
Mireille Cantarini
1 reference
Stuart Spencer
1 reference
Mark R Middleton
1 reference
1 reference
Identifiers
1 reference